文献速递母胎医学

无创游离胎儿DNA检测非整倍体:中国东南部31 515例单胎妊娠的多中心研究

Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-08

该多中心研究分析了中国福建省31 515例单胎妊娠的无创产前检测(NIPT)结果,按胎儿异常风险分为低、中、高危组,采用低覆盖全基因组测序和Z评分分析,阳性结果经羊膜腔穿刺核型分析确认。研究发现NIPT对T21、T18、T13和性染色体非整倍体的灵敏度分别为98.96%、100%、100%和100%,特异度均高于99.7%,支持NIPT用于育龄女性常见胎儿非整倍体的检测。

要点

  • NIPT对T21灵敏度98.96%(95/96),特异度99.94%(31 274/31 292)。
  • NIPT对T18、T13和SCA的灵敏度均为100%,特异度均高于99.7%。
  • T21和T18阳性预测值较高(84.07%和69.44%),T13和SCA中等(46.67%和42.66%)。

核心结论

  • 研究结果支持NIPT用于育龄女性常见胎儿非整倍体的可靠、准确检测。

研究设计与样本

  • 多中心研究,纳入中国福建省31 515例单胎妊娠,按胎儿异常风险分为低、中、高危组。
  • 采用低覆盖全基因组测序分析血浆游离DNA,标准Z评分识别胎儿非整倍体,阳性结果经羊膜腔穿刺核型分析确认。

主要发现

  • 研究人群NIPT检出染色体异常率为1.38%。
  • 高危组染色体异常率1.57%,高于中危组1.05%和低危组1.18%(P < 0.05)。
  • T21灵敏度98.96%(95/96),特异度99.94%(31 274/31 292);T18灵敏度100%(25/25),特异度99.96%(31 352/31 363)。
  • T13灵敏度100%(7/7),特异度99.97%(31 373/31 381);SCA灵敏度100%(61/61),特异度99.74%(31 245/31 327)。
  • 阳性预测值:T21为84.07%,T18为69.44%,T13为46.67%,SCA为42.66%。

临床怎么用

  • 作者结论认为研究结果支持NIPT用于育龄女性常见胎儿非整倍体的检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze the non-invasive prenatal testing (NIPT) for aneuploidy results of 31 515 singleton pregnancies in Fujian province, southeastern China, and assess its performance in low-, moderate- and high-risk pregnancies. METHODS: Women were categorized into groups according to whether their risk for fetal abnormality was low, moderate or high. Cell-free plasma DNA extracted from peripheral blood samples was subjected to low-coverage whole-genome sequencing. Standard Z-score analysis of the mapped sequencing reads was used to identify fetal aneuploidy, including the three main trisomies (T21, T18 and T13) and sex chromosome aneuploidy (SCA). NIPT-positive results were confirmed by amniocentesis and karyotyping. The performance of NIPT for detection of T21, T18, T13 and SCA was assessed by calculating the sensitivity and specificity. RESULTS: The rate of chromosomal abnormality detected by NIPT in the study population was 1.38%. A higher rate of chromosomal abnormality was found in the high-risk group (1.57%) compared to the moderate-risk (1.05%) and low-risk (1.18%) groups (P < 0.05). Sensitivity and specificity, respectively, were 98.96% (95/96) and 99.94% (31 274/31 292) for detection of T21, 100% (25/25) and 99.96% (31 352/31 363) for T18, 100% (7/7) and 99.97% (31 373/31 381) for T13 and 100% (61/61) and 99.74% (31 245/31 327) for SCA. Positive predictive values were high for T21 (84.07%) and T18 (69.44%) and moderate for T13 (46.67%) and SCA (42.66%). CONCLUSION: Our findings support the application of NIPT for reliable and accurate testing of the general population of reproductive-age women for clinically significant fetal aneuploidy. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Xu L, Huang H, Lin N, et al. Non-invasive cell-free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China. Ultrasound Obstet Gynecol. 2020. PMID: 31364782. doi:10.1002/uog.20416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。